BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 52 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,547,061 | +1.1% | 2,575,000 | 0.0% | 0.00% | 0.0% |
| Q1 2024 | $2,520,322 | -4.7% | 2,575,000 | -3.7% | 0.00% | 0.0% |
| Q4 2023 | $2,645,923 | +102.8% | 2,675,000 | +109.8% | 0.00% | 0.0% |
| Q1 2023 | $1,304,588 | -37.9% | 1,275,000 | -39.3% | 0.00% | 0.0% |
| Q3 2022 | $2,101,000 | +112.4% | 2,100,000 | +110.0% | 0.00% | – |
| Q2 2022 | $989,000 | +92.4% | 1,000,000 | +100.0% | 0.00% | – |
| Q3 2021 | $514,000 | -77.2% | 500,000 | -77.2% | 0.00% | -100.0% |
| Q1 2021 | $2,257,000 | +1120.0% | 2,193,000 | +1153.1% | 0.00% | – |
| Q3 2018 | $185,000 | -63.4% | 175,000 | -65.0% | 0.00% | -100.0% |
| Q2 2018 | $506,000 | -88.8% | 500,000 | -88.9% | 0.00% | -93.3% |
| Q3 2017 | $4,517,000 | – | 4,500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 25,130,000 | $26,845,000 | 3.25% |
| ZAZOVE ASSOCIATES LLC | 33,935,000 | $35,929,000 | 3.11% |
| Cheyne Capital Management (UK) LLP | 3,000,000 | $3,179,000 | 1.89% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 73,250,000 | $77,604,000 | 1.60% |
| Sonora Investment Management, LLC | 7,390,000 | $7,792,000 | 1.08% |
| Lombard Odier Asset Management (Europe) Ltd | 11,613,000 | $12,391,000 | 0.86% |
| SSI INVESTMENT MANAGEMENT LLC | 6,083,000 | $6,421,000 | 0.50% |
| MACKAY SHIELDS LLC | 53,388,000 | $57,017,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 18,865,000 | $20,150,000 | 0.27% |
| LOOMIS SAYLES & CO L P | 907,254 | $120,544,000 | 0.24% |